We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Connect Biopharma Holdings Inc | NASDAQ:CNTB | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.01 | 0.72% | 1.40 | 1.36 | 1.41 | 1.49 | 1.36 | 1.45 | 57,144 | 17:37:46 |
A live webcast will be available on the Company’s Investor Relations page, accessible here: https://investors.connectbiopharm.com/. A replay will be available on the Company’s website following the event.
About Connect Biopharma Holdings LimitedConnect Biopharma is a global, clinical-stage biopharmaceutical company dedicated to improving the lives of patients with inflammatory diseases through the development of therapies derived from T cell-driven research. It is building a rich pipeline of internally-designed, wholly-owned, small molecules and antibodies using functional cellular assays with T cells to screen and discover potent product candidates against validated immune targets. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. The Company’s second most advanced product candidate, CBP-307, is a modulator of a T-cell receptor known as S1P1 in development for the treatment of UC. Clinical development has begun for its third product candidate, CBP-174, a peripherally acting antagonist of histamine receptor 3, for the treatment of pruritus associated with AD.
With operations in the United States and China, Connect Biopharma is building a rich global pipeline of molecules and antibodies targeting several aspects of T cell biology. For additional information, please visit www.connectbiopharm.com.
IR/PR CONTACTS: Lazar FINN PartnersDavid Carey (IR)T: +1 (212) 867-1768david.carey@finnpartners.com
Glenn Silver (Media)T: +1 (973) 818-8198glenn.silver@finnpartners.com
Corporate Contacts:info@connectpharm.com
1 Year Connect Biopharma Chart |
1 Month Connect Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions